I-Sugammadex Sodium

Incazelo emfushane:

Igama le-API Inkomba Ukucaciswa I-US DMF I-EU DMF CEP
I-Sugammadex Sodium Ukuvinjelwa kwe-Neuromuscular Endlini      


Imininingwane Yomkhiqizo

Omaka bomkhiqizo

IMINININGWANE YOMKHIQIZO

舒更葡糖钠 I-Sugammadex Sodium 343306-79-6 Endlini

Incazelo

I-Sugammadex sodium iyi-synthetic γ-cyclodextrin derivative, futhi isebenza njenge-ejenti entsha yokuhlehla ye-neuromuscular block.

Igama elijwayelekile: sugammadex (soo GAM ma dex)
Igama lebrand: Bridion

I-Sugammadex ihlehlisa imiphumela yemithi ethile enikezwa ngesikhathi sokuhlinzwa ukuze uphumule imisipha yakho.

I-Sugammadex isetshenziswa ekupheleni kokuhlinzwa, ukusiza ukubuyisela ukusebenza kwemisipha okuye kwavinjelwa ngesikhathi sokuhlinzwa eminye imithi.

I-Sugammadex ingase isetshenziselwe izinjongo ezingabaliwe kulo mhlahlandlela wemithi.

Isetshenziselwa ukubuyisela emuva imiphumela yezinye izidakamizwa.

Ku-Vivo

Umjovo we-sugammadex awunayo imiphumela ebalulekile kumfutho wegazi noma ukushaya kwenhliziyo. Ngemuva kokujova umthamo ophezulu we-rocuronium, ukubuyiswa kwe-90% kwesilinganiso sesitimela-sesine kuthatha i-28 min (SD 7 min) ngemva kwe-saline, i-26 min (SD 9.5 min) ngemva kwe-1 mg / kg sugammadex, ne-8 min (SD) 3.6 min) ngemva kwe-2.5 mg/kg sugammadex[1]. I-Sugammadex ibangela ukuguqulwa okusheshayo nokuphelele kwe-rocuronium-induced neuromuscular block. Isikhathi sokutakula sokuqeqeshwa kwesilinganiso esine=0.9 ngemva kokululama okuzenzakalelayo siyimizuzu engu-14.4 (SD=3.4 min; n=14). Lokhu kuncishiswe kakhulu kumaminithi angu-3.7 (SD=3.3 min; n=4) nge-sugammadex 0.5 mg/kg futhi kuya ku-1.9 min (SD=1.0 min; n=4) nge-sugammadex 1.0 mg/kg[2]. Isilinganiso sempilo yesigamu se-sugammadex ku-Rhesus monkey singama-30 (SEM=4.9) amaminithi[3].

Isitoreji

Impushana

-20°C

3 iminyaka

4°C

iminyaka engu-2
Ku-solvent

-80°C

6 izinyanga

-20°C

Inyanga engu-1

Isakhiwo samakhemikhali

I-Sugammadex Sodium

ISItifiketi

2018 GMP-2
原料药GMP证书201811 (captopril,thalidomide njll)
I-GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
I-FDA-EIR-Letter-201901

UKUPHATHWA KWEKHWALITHI

Ukuphathwa kwekhwalithi1

Isiphakamiso18Amaphrojekthi Wokuhlola Ukuvumelana Kwekhwalithi asegunyaziwe4, futhi6amaphrojekthi angaphansi kokugunyazwa.

Ukuphathwa kwekhwalithi2

Uhlelo lokuphatha ikhwalithi yamazwe ngamazwe oluthuthukile lwenze isisekelo esiqinile sokuthengisa.

Ukuphathwa kwekhwalithi3

Ukugadwa kwekhwalithi kusebenza kuwo wonke umjikelezo wempilo womkhiqizo ukuze kuqinisekiswe ikhwalithi nomphumela wokwelapha.

Ukuphathwa kwekhwalithi4

Ithimba Lezindaba Zokulawula Ochwepheshe lisekela izimfuno zekhwalithi ngesikhathi sokufaka isicelo nokubhaliswa.

UKUPHATHWA KOMKHIQIZO

cpf5
cpf6

I-Korea Countec Bottled Packaging Line

cpf7
cpf8

I-Taiwan CVC Bottled Packaging Line

cpf9
cpf10

I-Italy CAM Board Packaging Line

cpf11

Umshini Wokuhlanganisa we-Fette waseJalimane

cpf12

I-Japan Viswill Tablet Detector

cpf14-1

I-DCS Control Room

UZAkwethu

Ukubambisana kwamazwe ngamazwe
Ukubambisana kwamazwe ngamazwe
Ukubambisana kwasekhaya
Ukubambisana kwasekhaya

  • Okwedlule:
  • Olandelayo:

  • Bhala umyalezo wakho lapha futhi usithumelele wona